ETON (STOCKS)
Eton Pharmaceutcials, Inc. Common Stock
$16.050000
+0.840000 (+5.52%)
Prev close: $15.210000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Sean E. Brynjelsen
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $444.10M
- Employees
- 31
- P/E (TTM)
- -64.43
- P/B (TTM)
- 17.64
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
6
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-0.07 | $0.09 | -0.1618 | -176.25% |
|
Jun 2025 (Q2)
|
$-0.10 | $-0.04 | -0.0626 | -167.38% |
|
Mar 2025 (Q1)
|
$0.07 | $0.05 | +0.0156 | +28.68% |
|
Dec 2024 (Q4)
|
$-0.02 | $0.00 | -0.0166 | -488.24% |
Financial Statements
| Revenues | $70.32M |
| Benefits Costs and Expenses | $76.80M |
| Cost Of Revenue | $34.20M |
| Costs And Expenses | $76.80M |
| Gross Profit | $36.12M |
| Operating Expenses | $38.80M |
| Depreciation and Amortization | $3.38M |
| Research and Development | $5.11M |
| Other Operating Expenses | $31.31M |
| Operating Income/Loss | -$2.68M |
| Income/Loss From Continuing Operations After Tax | -$6.68M |
| Income/Loss From Continuing Operations Before Tax | -$6.48M |
| Income Tax Expense/Benefit | $199.00K |
| Net Income/Loss | -$6.68M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$6.68M |
| Net Income/Loss Available To Common Stockholders, Basic | -$6.68M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.25 |
| Basic Average Shares | 53,863,000 |
| Assets | $104.51M |
| Current Assets | $72.00M |
| Inventory | $16.86M |
| Other Current Assets | $55.15M |
| Noncurrent Assets | $32.51M |
| Fixed Assets | $294.00K |
| Intangible Assets | $31.88M |
| Other Non-current Assets | $338.00K |
| Liabilities | $81.38M |
| Current Liabilities | $44.18M |
| Accounts Payable | $14.26M |
| Other Current Liabilities | $29.92M |
| Noncurrent Liabilities | $37.20M |
| Equity | $23.13M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $23.13M |
| Liabilities And Equity | $104.51M |
| Net Cash Flow From Operating Activities | $21.31M |
| Net Cash Flow From Operating Activities, Continuing | $21.31M |
| Net Cash Flow From Investing Activities | -$38.42M |
| Net Cash Flow From Investing Activities, Continuing | -$38.42M |
| Net Cash Flow From Financing Activities | $33.97M |
| Net Cash Flow From Financing Activities, Continuing | $33.97M |
| Net Cash Flow | $16.86M |
| Net Cash Flow, Continuing | $16.86M |
| Comprehensive Income/Loss | -$6.68M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$6.68M |
| Other Comprehensive Income/Loss | $0.00 |